Lyn R. Griffiths

After subsequently completing her honours degree, she was awarded an NHMRC Biomedical Postgraduate Scholarship to undertake her PhD at Sydney University.

In 2013, she relocated her laboratory to the Institute of Health and Biomedical Innovation at Queensland University of Technology, where she took up the role of Executive Director.

When the Institute was disbanded in 2020, she was appointed to the position of Inaugural Director of QUT's Centre of Genomics and Personalised Health.

[2][3] Prof. Griffiths’ research has led to diagnostic breakthroughs for several neurogenetic disorders, including familial migraine, ataxia, epilepsy and hereditary stroke.

[7] Additionally she has served on a number of boards to various bodies including the National Heart Foundation of Australia (Queensland Division),[8]